BLUE logo

bluebird bio (BLUE)

Profile

Full Name

bluebird bio, Inc.

Ticker Symbol

BLUE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 19, 2013

Indexes

Not included

Website

http://www.bluebirdbio.com

Employees

248

Key Details

Price

$4.15(-7.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$83.81M(+184.12% YoY)

Annual EPS

-$24.84(+35.63% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.15
BLUE price is $4.15

30-Day Relative Volume

1.24
BLUE 30-day relative volume is 1.24

Price Performance

Price Today change

-7.16%
BLUE price is down -7.16% today

Price YTD change

-50.24%
BLUE price is down -50.24% since January 1st

Price 1-year change

-79.04%
BLUE price is down -79.04% year-on-year

Price 3-year change

-95.43%
BLUE price is down -95.43% over the past 3 years

Price Range

Price All-time high

$3018.78
BLUE price is currently -99.86% below its historical high of $3018.78

Price 3-year low

$0.29
BLUE price is currently +1331.03% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$40.63M
BLUE market capitalization is $40.63 million

Market cap 3-year change

-87.47%
BLUE market capitalization is down -87.47% over the past 3 years

Market cap All-time high

$7.54B
BLUE market capitalization is currently -99.46% below its historical high of $7.54 billion

Market cap sector rank

35.03%
BLUE market capitalization is higher than 35.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.15%
BLUE shares outstanding is up +1.15% year-on-year

Shares Outstanding 3-Year Change

+174.09%
BLUE shares outstanding is up +174.09% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.29
BLUE beta is 1.29

200-day SMA

$10.29
BLUE price is currently -59.66% below its 200-day simple moving average

50-day SMA

$4.84
BLUE price is currently -14.28% below its 50-day simple moving average

RSI

46.52
BLUE 14-day relative strength index is 46.52

Volume

1.24
BLUE 30-day relative volume is 1.24

ATR

$0.44
BLUE average true range is $0.44

10-day Historical Volatility

80.85%
BLUE 10-day historical volatility is 80.85%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$83.81M
BLUE annual revenue is $83.81 million

Revenue Analysts estimate

$337.23M
BLUE annual revenue is currently -75.15% lower than the consensus analysts' forecast

Revenue 1-year change

+184.12%
BLUE annual revenue is up +184.12% year-on-year

Revenue Sector rank

54.53%
BLUE annual revenue is higher than 54.53% of companies in Healthcare sector

EPS

EPS

-$24.84
BLUE annual earnings per share is -$24.84

EPS Analysts estimate

$0.30
BLUE annual earnings per share is currently -8380.00% lower than the consensus analysts' forecast

EPS 1-year change

+35.63%
BLUE annual earnings per share is up +35.63% year-on-year

EPS Sector rank

5.88%
BLUE annual earnings per share is higher than 5.88% of companies in Healthcare sector

Profit

Gross profit

-$5.57M
BLUE annual gross profit is -$5.57 million

Gross margin

-6.65%
BLUE annual gross profit margin is -6.65%

Operating profit

-$267.70M
BLUE annual operating income is -$267.70 million

Operating margin

-319.42%
BLUE annual operating profit margin is -319.42%

Net income

-$240.72M
BLUE annual net profit is -$240.72 million

Net margin

-287.23%
BLUE annual net profit margin is -287.23%

Expenses

Total expenses

$351.51M
BLUE annual total expenses is $351.51 million

Operating expenses

$262.13M
BLUE annual total operating expenses is $262.13 million

Cost of goods sold

$89.38M
BLUE annual cost of goods sold is $89.38 million

Selling, general & administrative expenses

$167.87M
BLUE annual SGA is $167.87 million

Depreciation and amortization

$61.24M
BLUE annual depreciation & amortization is $61.24 million

Interest expense

$22.58M
BLUE annual interest expense is $22.58 million

Income tax

$70.00K
BLUE annual income tax is $70.00 thousand

EBIT & EBITDA

EBIT

-$218.07M
BLUE annual earnings before interest & taxes is -$218.07 million

EBITDA

-$156.82M
BLUE annual EBITDA is -$156.82 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$460.23M
BLUE annual total assets is $460.23 million

Non current assets

$305.56M
BLUE annual long term assets is $305.56 million

Current assets

$154.67M
BLUE annual total current assets is $154.67 million

Cash and cash equivalents

$62.30M
BLUE annual cash & cash equivalents is $62.30 million

Accounts receivable

$13.62M
BLUE annual accounts receivable is $13.62 million

Inventory

$65.02M
BLUE annual inventory is $65.02 million

Liabilities

Total liabilities

$491.77M
BLUE annual total liabilities is $491.77 million

Long term liabilities

$170.30M
BLUE annual total long term liabilities is $170.30 million

Current liabilities

$321.46M
BLUE annual total current liabilities is $321.46 million

Accounts payable

$34.32M
BLUE annual accounts payable is $34.32 million

Debt

Total debt

$358.24M
BLUE annual total debt is $358.24 million

Total debt 1-year change

+7.37%
BLUE annual total debt is up +7.37% year-on-year

Long term debt

$169.36M
BLUE annual long term debt is $169.36 million

Short term debt

$188.88M
BLUE annual short term debt is $188.88 million

Equity & Capital

Shareholders equity

-$31.53M
BLUE annual stockholders equity is -$31.53 million

Book value

-$31.53M
BLUE annual book value is -$31.53 million

Retained earnings

-$4.50B
BLUE annual retained earnings is -$4.50 billion

Working capital

-$166.79M
BLUE annual working capital is -$166.79 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$260.02M
BLUE annual cash flow from operations is -$260.02 million

Cash from operations 1-year change

-10.63%
BLUE annual cash flow from operations is down -10.63% year-on-year

Cash from investing

$3.90M
BLUE annual cash flow from investing activities is $3.90 million

Cash from investing 1-year change

-97.48%
BLUE annual cash flow from investing activities is down -97.48% year-on-year

Cash from financing

$87.47M
BLUE annual cash flow from financing activities is $87.47 million

Cash from financing 1-year change

-55.43%
BLUE annual cash flow from financing activities is down -55.43% year-on-year

CAPEX

CAPEX

$2.60M
BLUE annual capital expenditures is $2.60 million

CAPEX 1-year change

-71.3%
BLUE annual capital expenditures is down -71.3% year-on-year

Free Cash Flow

Free cash flow

-$262.62M
BLUE annual free cash flow is -$262.62 million

Free cash flow 1-year change

-7.59%
BLUE annual free cash flow is down -7.59% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-6.65%
BLUE annual gross profit margin is -6.65%

Operating margin

-319.42%
BLUE annual operating profit margin is -319.42%

Net margin

-287.23%
BLUE annual net profit margin is -287.23%

ROA & ROE

ROA

-44.60%
BLUE annual return on assets is -44.60%

ROE

-295.35%
BLUE annual return on equity is -295.35%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BLUE price to earnings ratio value is unknown

PE ratio Sector rank

-
BLUE price to earnings ratio is unknown

PB Ratio

PB ratio

-1.29
BLUE price to book ratio is -1.29

PB ratio Sector rank

7.65%
BLUE price to book ratio is higher than 7.65% of companies in Healthcare sector

PS Ratio

PS ratio

0.48
BLUE price to sales ratio is 0.48

PS ratio Sector rank

17.05%
BLUE price to sales ratio is higher than 17.05% of companies in Healthcare sector

Enterprise value

Enterprise value

$336.56M
BLUE enterprise value is $336.56 million

Enterprise value Sector rank

64.68%
BLUE enterprise value is higher than 64.68% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.14
BLUE EV/EBITDA is -2.14

EV/EBITDA Sector rank

30.55%
BLUE EV/EBITDA is higher than 30.55% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.48
BLUE annual current ratio is 0.48

Quick ratio

0.28
BLUE annual quick ratio is 0.28

Leverage

Debt to equity

-2.27
BLUE annual debt to equity ratio is -2.27

Interest coverage ratio

-9.66
BLUE annual interest coverage ratio is -9.66

Risk & Stability

Piotroski F-Score

3
BLUE piotroski f-score is 3

Altman Z-Score

-15.46
BLUE altman z-score is -15.46

Analyst ratings

Recent major analysts updates

Mar 31, 25 Barclays
Overweight
Feb 24, 25 Wells Fargo
Equal-Weight
Feb 24, 25 JP Morgan
Neutral
Dec 31, 24 Barclays
Overweight
Nov 15, 24 RBC Capital
Sector Perform
Nov 15, 24 Barclays
Overweight
Nov 15, 24 B of A Securities
Neutral
Sep 25, 24 Wells Fargo
Equal-Weight
Sep 16, 24 Cantor Fitzgerald
Neutral
Aug 15, 24 RBC Capital
Sector Perform

Institutional Ownership

Similar stocks

MRSN logo
Mersana Therapeutics (MRSN)
Pheton Holdings Ltd Class A (PTHL)
IPSC logo
Century Therapeutics (IPSC)
QNCX logo
Quince Therapeutics (QNCX)
MIST logo
Milestone Pharmaceuticals (MIST)
OTLK logo
Outlook Therapeutics (OTLK)
CCEL logo
Cryo-Cell International (CCEL)
ECOR logo
electroCore (ECOR)
PEPG logo
PepGen (PEPG)
  • What is the ticker symbol for bluebird bio?
  • Does bluebird bio pay dividends?
  • What sector is bluebird bio in?
  • What industry is bluebird bio in?
  • What country is bluebird bio based in?
  • When did bluebird bio go public?
  • Is bluebird bio in the S&P 500?
  • Is bluebird bio in the NASDAQ 100?
  • Is bluebird bio in the Dow Jones?
  • When was bluebird bio's last earnings report?
  • When does bluebird bio report earnings?
  • Should I buy bluebird bio stock now?

What is the ticker symbol for bluebird bio?

The ticker symbol for bluebird bio is NASDAQ:BLUE

Does bluebird bio pay dividends?

No, bluebird bio does not pay dividends

What sector is bluebird bio in?

bluebird bio is in the Healthcare sector

What industry is bluebird bio in?

bluebird bio is in the Biotechnology industry

What country is bluebird bio based in?

bluebird bio is headquartered in United States

When did bluebird bio go public?

bluebird bio's initial public offering (IPO) was on June 19, 2013

Is bluebird bio in the S&P 500?

No, bluebird bio is not included in the S&P 500 index

Is bluebird bio in the NASDAQ 100?

No, bluebird bio is not included in the NASDAQ 100 index

Is bluebird bio in the Dow Jones?

No, bluebird bio is not included in the Dow Jones index

When was bluebird bio's last earnings report?

bluebird bio's most recent earnings report was on Nov 14, 2024

When does bluebird bio report earnings?

The next expected earnings date for bluebird bio is May 9, 2025

Should I buy bluebird bio stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page